Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 5
2020 4
2021 3
2022 3
2023 13
2024 12
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Relevance of Computationally Derived Attributes of Arteries and Arterioles in focal segmental glomerulosclerosis and minimal change disease.
Zhou J, Demeke D, Li X, Dinh T, O'Connor C, Liu J, Zee J, Ozeki T, Chen Y, Janowczyk AR, Holzman L, Mariani LH, Bitzer M, Barisoni L, Hodgin JB, Lafata KJ. Zhou J, et al. medRxiv [Preprint]. 2025 Oct 13:2025.10.08.25336276. doi: 10.1101/2025.10.08.25336276. medRxiv. 2025. PMID: 41282757 Free PMC article. Preprint.
METHODS: We utilized one trichrome-stained WSI from 225 participants in the NEPTUNE/CureGN studies, comprising 127 cases of focal segmental glomerulosclerosis (FSGS) and 98 cases of minimal change disease (MCD). ...
METHODS: We utilized one trichrome-stained WSI from 225 participants in the NEPTUNE/CureGN studies, comprising 127 cases of focal seg …
Individualized treatment effects of corticosteroids in IgA nephropathy.
Hoelscher DL, Schmitz NE, Niggemeier L, Pilva P, Strauch M, Tesar V, Barratt J, Roberts IS, Coppo R; VALIGA investigators; Barisoni L; CureGN investigators; Yanagita M, Alabalik U, Rule AD, Jagtap JM, Abreu ES, Taal MW, Kalra PA; NURTuRE academic steering group; Floege J, Kramann R, Boor P; AI4IgAN study; Buelow RD. Hoelscher DL, et al. medRxiv [Preprint]. 2025 Oct 9:2025.10.08.25337548. doi: 10.1101/2025.10.08.25337548. medRxiv. 2025. PMID: 41282804 Free PMC article. Preprint.
Computational Characterization of Lymphocyte Topology on Whole Slide Images of Glomerular Diseases.
Li X, Shah M, Liu Q, Zhou J, Sotolongo G, Hodgin JB, Mariani L, Holzman L, Janowczyk AR, Zee J, Lafata KJ, Barisoni L. Li X, et al. J Am Soc Nephrol. 2025 Oct 8. doi: 10.1681/ASN.0000000889. Online ahead of print. J Am Soc Nephrol. 2025. PMID: 41066167
This study aims to computationally quantify lymphocyte topology and test its prediction of disease progression. METHODS: N=333 NEPTUNE/CureGN participants (N=155 focal segmental glomerulosclerosis, N=178 minimal change disease) with available clinical/demographic data and …
This study aims to computationally quantify lymphocyte topology and test its prediction of disease progression. METHODS: N=333 NEPTUNE/Cu …
Glomerular Segmentation, Classification, and Pathomic Feature-based Prediction of Clinical Outcomes in Minimal Change Disease and Focal Segmental Glomerulosclerosis.
Ambekar A, Roohian M, Liu Q, Wang B, Fan F, Cassol C, Lafata K, Holzman L, Mariani L, Hodgin J, Zee J, Janowczyk A, Barisoni L. Ambekar A, et al. medRxiv [Preprint]. 2025 Oct 7:2025.10.01.25336172. doi: 10.1101/2025.10.01.25336172. medRxiv. 2025. PMID: 41282794 Free PMC article. Preprint.
This study applies computational image analysis to (a) automate the segmentation and classification of glomeruli into GS, SS and non-GS/SS, (b) extract subvisual pathomic characteristics from non-GS/SS glomeruli, and (c) assess their clinical relevance. METHODS: Leveraging the NE …
This study applies computational image analysis to (a) automate the segmentation and classification of glomeruli into GS, SS and non-GS/SS, …
Polygenic Risk Scores and HLA Class II Variants are Biomarkers of Corticosteroid Response in Childhood Nephrotic Syndrome.
Tu T, Ochoa A, Sood A, Drabik A, Chryst-Stangl M, Lane B, Wu G, Donovan F, Harper U, Chandrasekharappa S, Esezobor C, Solarin A, Hooper D, Sethna C, Amaral S, Kallash M, Rheault M, Verghese P, Dharnidharka V, Salmon E, Weng P, Srivastava T, Seifert ME, Pruette C, Selewski D, Gibson K, Hunley T, Abeyagunawardena A, Thalgahagoda S, Bagga A, Sinha A, Webb N, Greenbaum L, Gharavi A, Kiryluk K, Kretzler M, Guay-Woodford L, Sanna-Cherchi S, Bierzynska A, Koziell A, Welsh G, Saleem M, Rotimi C, Chambers E, Chan C; CureGN Consortium; PNRC Glomerular disease group; CIBMTR/NMDP Consortium; Jackson A, Adeyemo A, Gbadegesin R. Tu T, et al. medRxiv [Preprint]. 2025 Aug 7:2025.08.01.25332825. doi: 10.1101/2025.08.01.25332825. medRxiv. 2025. PMID: 40970117 Free PMC article. Preprint.
Clinical relevance of computationally derived tubular features and their spatial relationships with the interstitial microenvironment in minimal change disease/focal segmental glomerulosclerosis.
Fan F, Liu Q, Zee J, Ozeki T, Demeke D, Yang Y, Bitzer M, O'Connor CL, Farris AB, Wang B, Shah M, Jacobs J, Mariani L, Lafata KJ, Rubin J, Chen Y, Holzman LB, Hodgin JB, Madabhushi A, Barisoni L, Janowczyk A. Fan F, et al. Kidney Int. 2025 Aug;108(2):293-309. doi: 10.1016/j.kint.2025.04.026. Epub 2025 May 21. Kidney Int. 2025. PMID: 40409668 Free article.
Ridge-penalized Cox models evaluated their predictive discrimination compared to clinical/demographic data and visual-assessment. Models were evaluated in the CureGN dataset. RESULTS: Nine features were predictive of disease progression and/or proteinuria remission. Models …
Ridge-penalized Cox models evaluated their predictive discrimination compared to clinical/demographic data and visual-assessment. Models wer …
Defining subgroups of pediatric nephrotic patients with urine proteomics.
Cummins TD, Mariani LH, Wilkey DW, Jortani SA, Helmuth M, Rane MJ, Merchant ML, Kamigaki Y, Theesfeld C, McCown PJ, Ju W, Dougherty JA, McRitchie S, Pathmasiri W, Kretzler M, Sumner SJ, Smoyer WE, Klein JB; Cure Glomerulonephropathy (CureGN) Consortium. Cummins TD, et al. Sci Rep. 2025 Jul 11;15(1):25064. doi: 10.1038/s41598-025-05150-6. Sci Rep. 2025. PMID: 40646010 Free PMC article.
Using quantitative proteomics, urine proteins from children with MCD and FSGS in the CureGN Study were identified and correlated with disease onset and activity. Unbiased cluster analyses of nephrotic urine proteomes demonstrated a cluster with relatively increased immune …
Using quantitative proteomics, urine proteins from children with MCD and FSGS in the CureGN Study were identified and correlated with …
Risk Factors for Disease Progression for Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN).
Laurin LP, Helmuth M, Almaani S, Ayoub I, Chen DP, Villegas LA, Nast CC, Robinson BM, Derebail VK, Waldman M, Bomback AS; CureGN Consortium. Laurin LP, et al. Kidney Int Rep. 2025 Mar 24;10(6):1917-1928. doi: 10.1016/j.ekir.2025.03.027. eCollection 2025 Jun. Kidney Int Rep. 2025. PMID: 40630289 Free PMC article.
METHODS: We used the Cure Glomerulonephropathy (CureGN) prospective cohort of patients with pMN diagnosed using biopsy between 2010 and 2023. ...
METHODS: We used the Cure Glomerulonephropathy (CureGN) prospective cohort of patients with pMN diagnosed using biopsy between 2010 a …
Cardiovascular and Thromboembolic Events in Children and Adults With Glomerular Disease: Findings From the Cure GlomeruloNephropathy (CureGN) Network.
Wadhwani S, Mansfield SA, Smith AR, Robinson BM, Abdelghani E, Al-Uzri A, Ashoor IF, Bartosh SM, Chishti AS, Hayek SS, Hladunewich MA, Kerlin BA, Madapoosi SS, Mariani LH, Mottl AK, Rheault MN, O'Shaughnessy MM, Sperati CJ, Srivastava T, Selewski DT, Wang CS, Wong CS, Weaver DJ Jr, Khalid M; GlomeruloNephropathy (CureGN) Study Consortium. Wadhwani S, et al. Kidney Med. 2024 Jul 20;7(6):100877. doi: 10.1016/j.xkme.2024.100877. eCollection 2025 Jun. Kidney Med. 2024. PMID: 40510608 Free PMC article.
This analysis describes CV and TE outcomes in the Cure GlomeruloNephropathy (CureGN) Network. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: CureGN is a prospective cohort study of children and adults with biopsy-proven minimal change disease (M …
This analysis describes CV and TE outcomes in the Cure GlomeruloNephropathy (CureGN) Network. STUDY DESIGN: Prospective cohort study. …
54 results